logo
India conducts first human gene therapy trial for haemophilia

India conducts first human gene therapy trial for haemophilia

Time of India25-04-2025
Bengaluru: A collaboration between Biotechnology Research and Innovation Council's Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem) in Bengaluru and
CMC Vellore
has resulted in the country's first human gene therapy trial for haemophilia, officials announced on Thursday.
Haemophilia is a genetic blood disorder in which blood doesn't clot normally, causing abnormal bleeding.
Union science and technology minister Jitendra Singh reviewed progress in the work during an inspection of facilities at BRIC-inStem. "This is a milestone in India's scientific journey," he said, highlighting the institute's contributions to preventive and regenerative healthcare.
Singh toured BRIC-inStem's Biosafety Level III laboratory, a critical national facility for studying high-risk pathogens under India's One Health Mission. "The pandemic taught us that we must always be prepared. Facilities like this will keep us ahead of hazards." The newly launched Centre for Research Application and Training in Embryology (CReATE) came in for praise for its work on addressing birth defects and infertility through developmental biology research.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

80% population in Odisha vulnerable to Hepatitis B: Prof SP Singh
80% population in Odisha vulnerable to Hepatitis B: Prof SP Singh

New Indian Express

time2 hours ago

  • New Indian Express

80% population in Odisha vulnerable to Hepatitis B: Prof SP Singh

BHUBANESWAR: Over 80 per cent of Odisha's total population is still vulnerable to Hepatitis B infection that can simply be prevented through vaccination, said renowned gastroenterologist Prof SP Singh on Sunday. Speaking to TNIE on the eve of World Hepatitis Day, Prof Singh said about 0.9 per cent of population in the state is affected with Hepatitis B and the trend remains almost same for the last two-and-half decades. 'However, a majority of the population is still unaware of the infection, caused by the Hepatitis B virus (HBV), impacting both prevention and control efforts,' he said. The chairman of the Kalinga Gastroenterology Foundation (KGF) said in a study carried out in Cuttack a few years back, the awareness among the people about the disease and vaccine was found to be just about 38 per cent and 32 per cent, respectively. Besides, about 50 per cent of those who were aware had no knowledge about the route of transmission, infectivity or importance of vaccination. The percentage of vaccination was also a mere 20. He called for stronger adherence to World Health Organisation (WHO)'s comprehensive approach to hepatitis that includes 'screen all, vaccinate all and treat all' to protect the population that has never been a part of the vaccination programme. He also sought compulsory vaccination for children in all schools. The KGF is set to celebrate its 25th Hepatitis B Eradication Day and the 15th World Hepatitis Day on Monday with this year's theme 'Lets Break Down.' The KGF will also present three awards - Blumberg Oration Award to eminent hepatologist Prof Nancy Reau from Chicago, KGF Samman to Prof Anup Kumar Das from AMC, Dibrugarh and Siba Panigrahi Samman to sculptor Sanjib Biswal.

Earth observation NISAR satellite will be launched on July 30, says ISRO chairman
Earth observation NISAR satellite will be launched on July 30, says ISRO chairman

The Hindu

time2 hours ago

  • The Hindu

Earth observation NISAR satellite will be launched on July 30, says ISRO chairman

The unique Earth observation satellite NASA-ISRO Synthetic Aperture Radar (NISAR) will be launched through the GSLV-S16 on July 30, said ISRO chairman V Narayanan. Weighing 2,392 kg, NISAR is a unique Earth observation satellite and the first to observe the Earth with a dual-frequency Synthetic Aperture Radar (NASA's L-band and ISRO's S-band) both using NASA's 12m unfurlable mesh reflector antenna, integrated to ISRO's modified 13k satellite bus. It will observe earth with a swath of 242 km and high spatial resolution, using SweepSAR technology for the first time, according to the space agency. It will be launched from the Satish Dhawan Space Centre, Sriharikota. 'The Earth observation satellite jointly developed by ISRO and NASA will be sent into space on July 30 by the GSLV-F16 rocket made in India,' Indian Space Research Organisation chairman V Narayanan said. It will be launched at a distance of 740 km. It can take pictures of the earth 24 hours a day in all weather conditions and the satellite can detect landslides, aid in disaster management and monitor climate change, he said while speaking to reporters at the airport in Chennai on Sunday (July 27, 2025) night. 'The satellite will benefit India, the U.S. and the entire world… it is also crucial for monitoring earth's natural resources,' he added. On Gaganyaan, India's human spaceflight Mission, Narayanan said a humanoid, called Vyommitra, will be sent into space in December this year. Once it proved to be successful, two other uncrewed missions would be launched next year. Following the success, the Gaganyaan Mission will be launched in March 2027 as Prime Minister Narendra Modi has said. 'NISAR' launch will upscale ISRO's international collaborations, says Jitendra Singh Union Minister for Science and Technology Dr Jitendra Singh disclosed that the much-anticipated launch of the NASA-ISRO Synthetic Aperture Radar (NISAR) satellite mission is scheduled for July 30, 2025, at 17:40 hrs from the Satish Dhawan Space Centre, Sriharikota. As the first joint Earth observation mission between the Indian Space Research Organisation (ISRO) and the United States' National Aeronautics and Space Administration (NASA), the event marks a defining moment in the journey of Indo-US space cooperation and also in ISRO's overall international collaborations, he said. The mission will be launched aboard India's GSLV-F16 rocket. Mr. Singh, who has been monitoring the mission closely, said the launch reflects the maturing of strategic scientific partnerships and India's emergence as a credible global player in advanced Earth observation systems. While expressing his wish to be physically present in Sriharikota to witness the historic event, the Minister acknowledged that the ongoing Parliament session may hold him back in Delhi. 'This mission is not just about a satellite launch--it is a moment that symbolises what two democracies committed to science and global welfare can achieve together. NISAR will not only serve India and the United States but will also provide critical data for countries around the world, especially in areas like disaster management, agriculture, and climate monitoring,' said Dr Singh. Mr. Singh further noted that this mission lives up to Prime Minister Narendra Modi's vision of India becoming a 'Vishwa Bandhu'--a global partner that contributes to the collective good of humanity. A key feature of the mission is that all data generated by NISAR will be made freely accessible within one to two days of observation and in near real-time in case of emergencies. This democratisation of data is expected to support global scientific research and decision-making, especially for developing countries that may not have access to similar capabilities. Notably, the NISAR mission is the first time a GSLV rocket is being used to place a satellite in sun-synchronous polar orbit, signalling ISRO's growing technical sophistication in supporting diverse space missions. The dual radar payload aboard NISAR will employ SweepSAR technology for high-resolution, all-weather, day-and-night imaging of the Earth's surface with a wide swath of 242 kilometres. The Union Minister also underlined the importance of Earth observation missions in the context of climate resilience and sustainable development. 'Missions like NISAR are no longer confined to scientific curiosity — they are instrumental in planning, risk assessment, and policy intervention. As climate change impacts intensify, timely and accurate data from satellites like NISAR will be indispensable for governments to act proactively,' he said. While the mission has seen a long gestation period of over a decade and a joint investment exceeding $1.5 billion, the payoff in terms of global utility and technological advancement is expected to be transformative. The launch of NISAR is being closely watched by space agencies, environmental researchers, and policymakers worldwide. As the countdown to July 30 begins, Dr Jitendra Singh reiterated that India's space program under the guidance of Prime Minister Modi is steadily transitioning from traditional utility-based missions to those that position the country as a knowledge contributor to the global commons. 'NISAR is not just a satellite; it is India's scientific handshake with the world,' he said. (With inputs from ANI)

Snakebites: When Is It Too Late For Anti-Venom Injection?
Snakebites: When Is It Too Late For Anti-Venom Injection?

News18

time3 hours ago

  • News18

Snakebites: When Is It Too Late For Anti-Venom Injection?

Last Updated: If you live in a snake-prone area during monsoon, stay alert. Some snakes are highly venomous, and without quick anti-venom treatment, their bite can be deadly Cases of snake bites tend to rise during the rainy season because rainwater floods their burrows, forcing snakes to come out. In search of drier shelter, they often move towards houses or hide in nearby trees, plants, or bushes. India is home to nearly 400 species of snakes, out of which around 60 are venomous. The Russell's viper, Indian cobra, common krait, and saw-scaled viper are considered the most dangerous. If you live in an area prone to snake sightings during the monsoon, it's important to remain extra cautious. Many snakes are so venomous that without immediate medical intervention, including an anti-venom injection, the bite can be fatal. In this situation, knowing how soon anti-venom should be administered after a snake bite and how much anti-venom is required becomes important to save lives in critical situations. In conversation with Dr Dilip Singh, Chief Medical Superintendent at the Government Medical College, Kannauj, Uttar Pradesh, he tried to answer these important questions: Injection For Snake Bite Dr Dilip Singh explains that the snake anti-venom injection is a prescription medicine given as treatment for venomous snake bites. It is regarded as the most effective remedy for such cases. The anti-venom used is a combination designed to counteract the venom of four major types of snakes. It works by neutralising the venom and can save lives even after a bite from a venomous snake. According to Dr Singh, an anti-venom injection is not needed for non-venomous snake bites. However, in the case of venomous bites, such as those from a cobra or krait, the anti-venom must be administered immediately, ideally within 30 to 40 minutes. If given even earlier, the chances of a faster recovery increase. In some cases, the injection can still be beneficial if administered within 24 hours. Which Venom Attacks Which Organ? According to the expert, before administering anti-venom, it is crucial to understand what kind of snake venom is involved and its effect on the body. Snake venom is broadly categorised into two types: cardiotoxic and neurotoxic. These affect the nervous system and cardiovascular system, respectively. In cardiotoxic cases, symptoms can include heart failure, an increased heart rate, and high or low blood pressure. In neurotoxic cases, patients may experience unconsciousness, fainting, and high-grade fever. Dose Of Anti-Venom According to Dr Singh, the required dose of anti-venom depends on the condition of the patient. In some cases, where the effect of the venom is mild, only one dose is needed. In more serious cases, patients may require three or four follow-up doses. If the snake is highly venomous, a larger quantity of anti-venom may be needed, as each dose may contain fewer antibodies. Types of poison Neurotoxic Poison: This type of venom affects the nervous system, leading to muscle weakness, paralysis, and even death. Neurotoxin is commonly found in snakes like the cobra, krait, and viper. Haemotoxic Poison: This venom damages blood vessels, which can lead to bleeding, organ failure, and death. Haemotoxin is usually found in snakes like the Russell's viper, tiger snake, and king cobra. Cytotoxic Poison: This type of venom destroys body tissues, resulting in swelling, pain, and potentially death. Cytotoxin is usually found in snakes like the rattlesnake, boa constrictor, and python. Location : Kannauj, India, India First Published: July 28, 2025, 10:28 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store